Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fengshi mud
- Development stage
- Preclinical
- Administration
- Topical
01
Overview
Fengshi mud is referenced in the context of traditional Chinese medicine and integrative therapies, particularly for the treatment of rheumatoid arthritis, including malignant rheumatoid arthritis. It appears as part of combination interventions in clinical trials (e.g., "RA No.1 + fengshi mud") for these conditions. However, there is no evidence that "fengshi mud" is a standardized pharmaceutical product or a well-defined dietary supplement; rather, it seems to be a component or formulation used within traditional medicine practices[2][4]. There are no details available regarding its precise composition, mechanism of action, or regulatory approval status.
- Other names
- fengshi mud
Beyond the preview
Go deeper on fengshi mud.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fengshi mud.